Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02908802
Other study ID # 40-16
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date October 2019

Study information

Verified date September 2018
Source Tel Hai College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Subjects will answer the following questionnaire and tests:

- Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

- Demographic Questionnaire - composed by the researchers

- Family Eating Habits Questionnaire (FEAHQ-33)

- Food Frequency Questionnaire (FFQ)

- Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.


Description:

Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age.

Subjects will answer the following questionnaire and tests:

- Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

- Demographic Questionnaire - composed by the researchers

- Family Eating Habits Questionnaire (FEAHQ-33)

- Food Frequency Questionnaire (FFQ)

- Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 45
Est. completion date October 2019
Est. primary completion date September 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 30 Years
Eligibility Inclusion Criteria:

- Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist,

- Students who are not treated by medication or alternative treatment,

- Students who are not due to complete their education at Tel Hai College during the study period,

- Students who have signed on an informed consent form,

- No dairy intolerance (student can consume milk without any adverse effects),

- No soy allergy,

- Not currently taking any antibiotics or probiotics,

- Not pregnant or planning to become pregnant during the study period,

- Not been diagnosed with any of the following:

- Cancer

- HIV/AIDS

- Crohn's disease

- Ulcerative colitis

- Immune compromised illness

- Other serious illness

Exclusion Criteria:

- Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder,

- Students who have not been assessed by MATAL and a psychiatrist,

- Students who take antibiotics.

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Hyperkinesis

Intervention

Dietary Supplement:
Probiotic
Probiotic
Placebo
Probiotics capsules without the active ingredient

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tel Hai College

Outcome

Type Measure Description Time frame Safety issue
Primary Reduce symptoms of attention deficit measured by MOXO test After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test Six month
See also
  Status Clinical Trial Phase
Completed NCT03260205 - Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) Phase 3
Withdrawn NCT03546400 - Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. Phase 4
Completed NCT02917109 - LearningRx Cognitive Training for ADHD N/A
Completed NCT02248948 - Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children N/A
Recruiting NCT01750307 - The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment) N/A
Recruiting NCT06170996 - Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00735371 - Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 3
Withdrawn NCT03580005 - A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. Phase 4
Completed NCT02578030 - Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD Phase 1
Completed NCT02574273 - Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) N/A
Completed NCT02257216 - Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) N/A
Recruiting NCT04943796 - A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
Recruiting NCT04634006 - Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study N/A
Completed NCT02604407 - Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Phase 3
Completed NCT05870605 - Drug Use Study With Intuniv® in European Countries
Terminated NCT03481959 - Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity Phase 3
Terminated NCT03638466 - Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder Phase 2
Completed NCT03709940 - Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02795637 - Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction Phase 1
Completed NCT01533493 - Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study N/A